Neuromuscular Diseases

• Neuromuscular Disease Center at Washington University School of Medicine, St Louis (US)
• Neuromuscular & Central Nervous System Syndromes - Washington University School of Medicine, St Louis (US)
• MEDLINE
• Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A 1998 Dec 22;95(26):15603-7.Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Department of Physiology, A700 Richards Building, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6085, USA.
• Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science 1998 Dec 11;282(5396):2076-9 .Rambukkana A, Yamada H, Zanazzi G, Mathus T, Salzer JL, Yurchenco PD, Campbell KP, Fischetti VA
• Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 1998 Dec 11;282(5396):2079-81. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB
• A pilot trial of prednisone in facioscapulohumeral muscular dystrophy.FSH-DY Group. Neurology 1997 Jan;48(1):46-9. Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, Griggs RC. Department of Neurology, University of Rochester School of Medicine and Dentistry, NY 14642, USA.
• Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group. Neurology 1998 May;50(5):1402-6. Kissel JT, McDermott MP, Natarajan R, Mendell JR, Pandya S, King WM, Griggs RC, Tawil R. Department of Neurology, Ohio State University, Columbus 43210, USA.
• Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 1995 Sep 28;333(13):832-8. Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R, et al. Department of Neurology, Ohio State University, Columbus 43210, USA.
• Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months). Neurology 1993 Mar;43(3 Pt 1):520-7. Griggs RC, Moxley RT 3d, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP, Cwik VA, Pandya S, Robison J, et al. Department of Neurology, University of Rochester, NY.
• Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat Genet 1997 Aug;16(4):407-9. Thornton CA, Wymer JP, Simmons Z, McClain C, Moxley RT 3rd. Department of Neurology, School of Medicine and Dentistry, University of Rochester, NY 14642, USA.
• Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism.  Am J Hum Genet 1993 May;52(5):875-83. Lavedan C, Hofmann-Radvanyi H, Shelbourne P, Rabes JP, Duros C, Savoy D, Dehaupas I, Luce S, Johnson K, Junien C. INSERM, Unite 73, Paris, France.
• Paternal transmission of congenital myotonic dystrophy. J Med Genet 1994 Jul;31(7):518-20.  Bergoffen J, Kant J, Sladky J, McDonald-McGinn D, Zackai EH, Fischbeck KH. Department of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, PA 19104.
• Mutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression.  Hum Mol Genet 1998 May;7(5):855-64. Manilal S, Recan D, Sewry CA, Hoeltzenbein M, Llense S, Leturcq F, Deburgrave N, Barbot J, Man N, Muntoni F, Wehnert M, Kaplan J, Morris GE. MRIC Biochemistry Group, NE Wales Institute, Wrexham LL11 2AW, UK.